The Contagion® Respiratory Infections specialty page provides respiratory infection-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
Gilead Sciences is collaborating with Chinese, US, and global health officials in order to investigate the safety and efficacy of their investigational antiviral compound remdesivir against the novel coronavirus.
The WHO International Health Regulations Emergency Committee convened on January 22rd to discuss the status of the coronavirus outbreak. The committee was split on their decision and will reconvene on January 23rd.
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512